This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Med Ad News Announces Nominees For The 24th Annual Manny Awards As Well As Industry Person Of The Year, Faruk Capan

Med Ad News congratulates Industry Person of the Year Faruk Capan and all award nominees.

The 24th annual Manny Awards celebration on Thursday, April 25, 2013, at Pier Sixty at Chelsea Piers in New York, N.Y., will begin with a cocktail hour at 6:30 p.m., followed by a sit-down dinner at 7:30 p.m., and will conclude with a post-awards cocktail hour. The awards ceremony will commence at 8:30 p.m. The event is black tie.

For reservations, visit www.mannyawards.com or contact Joanna Siddiqui at joanna.siddiqui@ubm.com

For sponsorship opportunities, contact: Daniel Becker at (973) 808-1191 or Daniel.Becker@ubm.com

Press inquiries, contact: Joanna Siddiqui at (973) 808-8847 or Joanna.Siddiqui@ubm.com

About the Manny AwardsFor more than 20 years, the Med Ad News Manny Awards have paid tribute to the creative work of agencies serving the healthcare market, their people, and their contributions to the industry. Each year at this gala awards ceremony, Med Ad News and agency professionals come together to celebrate creative excellence in pharmaceutical and medical device advertising and to acknowledge those making significant contributions to healthcare communications. On this special evening, more than 600 industry peers are anticipated to join Med Ad News in honoring winners in a range of award categories.

About Med Ad News The pharmaceutical industry's publication of record for 30 years, Med Ad News provides broad coverage and incisive analysis of the issues, events, trends, and strategies shaping pharmaceutical business, marketing, and sales. More than 16,500 readers – comprising corporate executives, marketing, sales, and product managers – receive Med Ad News 12 times per year. Med Ad News is a publication of UBM Canon Pharmaceutical Media Group. For more info, visit www.pharmalive.com.

About UBM CanonUBM Canon, the leading B-to-B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM plc (UBM.L) a global provider of media and information services for professional B2B communities and markets.

SOURCE UBM Canon; Med Ad News

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs